Cargando…
Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome
BACKGROUND: Biliary tract cancer (BTC) is a Lynch syndrome (LS)-associated cancer with a high mortality rate. This study aimed to clarify the clinical features of BTC in individuals with LS and to discuss its management. METHODS: We obtained data from genetically verified Japanese individuals with L...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660066/ https://www.ncbi.nlm.nih.gov/pubmed/36388648 http://dx.doi.org/10.21037/jgo-22-165 |
_version_ | 1784830343091585024 |
---|---|
author | Kanaya, Nobuhiko Aoki, Hideki Morito, Toshiaki Taniguchi, Fumitaka Shigeyasu, Kunitoshi Tamura, Chieko Sugano, Kokichi Akagi, Kiwamu Ishida, Hideyuki Tanakaya, Kohji |
author_facet | Kanaya, Nobuhiko Aoki, Hideki Morito, Toshiaki Taniguchi, Fumitaka Shigeyasu, Kunitoshi Tamura, Chieko Sugano, Kokichi Akagi, Kiwamu Ishida, Hideyuki Tanakaya, Kohji |
author_sort | Kanaya, Nobuhiko |
collection | PubMed |
description | BACKGROUND: Biliary tract cancer (BTC) is a Lynch syndrome (LS)-associated cancer with a high mortality rate. This study aimed to clarify the clinical features of BTC in individuals with LS and to discuss its management. METHODS: We obtained data from genetically verified Japanese individuals with LS who were diagnosed at a single institution, between January 2003 and April 2021. Moreover, 21 individuals with sporadic BTC (n=15) and LS associated BTC (n=6) underwent microsatellite instability (MSI) testing. RESULTS: Among 92 individuals with LS, 6 individuals with MLH1 variants developed BTCs (10 lesions, male/female, 2:1). The median age at diagnosis of initial BTC was 69 years (range, 34–78 years). Histological examination revealed a predominance of differentiated adenocarcinoma (89%). Then, 2 individuals had multiple BTCs. All available 7 BTC lesions showed high-frequency of microsatellite instability (MSI-H). MLH1 carriers showed a 7.2% cumulative risk of BTC development at an age of 70 years. Five of the six individuals died of BTC. CONCLUSIONS: MSI analysis could facilitate LS identification in individuals with BTC. Surveillance for BTC should be considered for MLH1 carriers in Japan. |
format | Online Article Text |
id | pubmed-9660066 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-96600662022-11-15 Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome Kanaya, Nobuhiko Aoki, Hideki Morito, Toshiaki Taniguchi, Fumitaka Shigeyasu, Kunitoshi Tamura, Chieko Sugano, Kokichi Akagi, Kiwamu Ishida, Hideyuki Tanakaya, Kohji J Gastrointest Oncol Original Article BACKGROUND: Biliary tract cancer (BTC) is a Lynch syndrome (LS)-associated cancer with a high mortality rate. This study aimed to clarify the clinical features of BTC in individuals with LS and to discuss its management. METHODS: We obtained data from genetically verified Japanese individuals with LS who were diagnosed at a single institution, between January 2003 and April 2021. Moreover, 21 individuals with sporadic BTC (n=15) and LS associated BTC (n=6) underwent microsatellite instability (MSI) testing. RESULTS: Among 92 individuals with LS, 6 individuals with MLH1 variants developed BTCs (10 lesions, male/female, 2:1). The median age at diagnosis of initial BTC was 69 years (range, 34–78 years). Histological examination revealed a predominance of differentiated adenocarcinoma (89%). Then, 2 individuals had multiple BTCs. All available 7 BTC lesions showed high-frequency of microsatellite instability (MSI-H). MLH1 carriers showed a 7.2% cumulative risk of BTC development at an age of 70 years. Five of the six individuals died of BTC. CONCLUSIONS: MSI analysis could facilitate LS identification in individuals with BTC. Surveillance for BTC should be considered for MLH1 carriers in Japan. AME Publishing Company 2022-10 /pmc/articles/PMC9660066/ /pubmed/36388648 http://dx.doi.org/10.21037/jgo-22-165 Text en 2022 Journal of Gastrointestinal Oncology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Kanaya, Nobuhiko Aoki, Hideki Morito, Toshiaki Taniguchi, Fumitaka Shigeyasu, Kunitoshi Tamura, Chieko Sugano, Kokichi Akagi, Kiwamu Ishida, Hideyuki Tanakaya, Kohji Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome |
title | Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome |
title_full | Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome |
title_fullStr | Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome |
title_full_unstemmed | Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome |
title_short | Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome |
title_sort | clinical features of biliary tract cancer in japanese individuals with lynch syndrome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660066/ https://www.ncbi.nlm.nih.gov/pubmed/36388648 http://dx.doi.org/10.21037/jgo-22-165 |
work_keys_str_mv | AT kanayanobuhiko clinicalfeaturesofbiliarytractcancerinjapaneseindividualswithlynchsyndrome AT aokihideki clinicalfeaturesofbiliarytractcancerinjapaneseindividualswithlynchsyndrome AT moritotoshiaki clinicalfeaturesofbiliarytractcancerinjapaneseindividualswithlynchsyndrome AT taniguchifumitaka clinicalfeaturesofbiliarytractcancerinjapaneseindividualswithlynchsyndrome AT shigeyasukunitoshi clinicalfeaturesofbiliarytractcancerinjapaneseindividualswithlynchsyndrome AT tamurachieko clinicalfeaturesofbiliarytractcancerinjapaneseindividualswithlynchsyndrome AT suganokokichi clinicalfeaturesofbiliarytractcancerinjapaneseindividualswithlynchsyndrome AT akagikiwamu clinicalfeaturesofbiliarytractcancerinjapaneseindividualswithlynchsyndrome AT ishidahideyuki clinicalfeaturesofbiliarytractcancerinjapaneseindividualswithlynchsyndrome AT tanakayakohji clinicalfeaturesofbiliarytractcancerinjapaneseindividualswithlynchsyndrome |